The American Heart Association has published new clinical guidance on infective endocarditis, covering diagnosis, antibiotic therapy, and patient management. The material was released through the organization’s professional website, professional.heart.org, on September 8, 2026.
Infective endocarditis is a serious infection of the inner lining of the heart chambers and valves. According to professional.heart.org, the guidance addresses key aspects of care, including how to accurately diagnose the condition and how to select appropriate antibiotic treatment. The document also outlines broader management strategies for affected patients.
The publication serves as a reference for clinicians who treat patients with this infection. Because the source material is limited to a headline and summary, no specific recommendations, statistics, or study findings are available at this time. The guidance appears intended to support healthcare providers in making evidence-based decisions in clinical practice.
The American Heart Association regularly updates its clinical guidance to reflect the latest research and best practices. This latest release adds to the organization’s body of resources for cardiovascular care.
What to watch next: Further details from the full guidance document may emerge as it becomes more widely available to medical professionals.
